Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells
Narendiran Rajasekaran, Xiaoguang Wang, Sruthi Ravindranathan, Daniel J. Chin, Su Yi Tseng, Scott L. Klakamp, Kate Widmann, Varun N. Kapoor, Vladimir Vexler, Patricia Keegan, Sheng Yao, Theresa LaVallee, Sanjay D. Khare
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cells'. Together they form a unique fingerprint.